A study evaluating the effect of Educational Needs Assessment Tool (ENAT) focused patient education on health outcomes in patients with rheumatoid arthritis

A multicentre randomised controlled interventional process of care study evaluating the effect of Educational Needs Assessment Tool (ENAT) focused patient education on health outcomes in patients with rheumatoid arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN51523281

Enrollment

130

Registered

2011-01-21

Start date

2010-06-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Musculoskeletal

Interventions

130 RA patients will be randomised into an Experimental Group (EG) or Control Group (CG). The EG will complete the ENAT priot to seeing a Clinical Nurse Specialist (CNS) at weeks 0, 16 and 32. For t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Positive diagnosis of rheumatoid arthritis defined by the American Rheumatism Association (ARA) criteria 2. Aged 18 years or above, either sex 3. Ability to complete questionnaires unaided

Exclusion criteria

Exclusion criteria: Patients with a history of severe mental health problems which would impair their ability to provide informed consent should be excluded

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of ENAT-focused patient education on the health outcomes of RA patients, measured at baseline, 16 weeks and 32 weeks.	—

Secondary

Measure	Time frame
1. To establish whether the patients perceive they are getting an equally good or inadequate education 2. To evaluate the usability of the ENAT in a clinical setting Measured at baseline, 16 weeks and 32 weeks.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026